Vaccine Injury: Recognition, Research and Re-establishing Trust

Background : Patients who report serious health changes following vaccination frequently face barriers to recognition, coordinated evaluation, and treatment. The October 5, 2026, Health and Human Services (HHS) Vaccine Injury Roundtable at the National Institutes of Health (NIH) brought patient, family, physician, and federal leadership perspectives into direct dialogue and highlighted an urgent need for compassionate care and rigorous inquiry. Clinical Perspectives : Three physicians described distinct but overlapping concerns. A pediatrician with extensive experience caring for children with autism and complex chronic illness called for research into biologic susceptibility, post-vaccination regression, and treatment strategies for affected children. A second pediatrician raised questions about chronic inflammation, neurodevelopmental conditions, vaccine components, and the need for research into individual vulnerability and long-term outcomes. A neurologist described complex, multi-system presentations among patients with suspected post-acute coronavirus disease 2019 (COVID-19) vaccination syndrome, including neurologic, autonomic, cognitive, cardiopulmonary, and immune-related symptoms. Call to Action : The authors commend HHS and NIH for establishing a clinic to study patients reporting vaccine-related injuries. However, the national need is for urgent clinical care and educating clinicians on how to deliver it. Priority actions include prospective longitudinal studies; standardized clinical phenotyping; transparent case definitions; improved adverse-event surveillance; research into genetic, metabolic, mitochondrial, immunologic, and inflammatory susceptibility factors; and a national network of multidisciplinary referral and treatment centers. Conclusions : Patient testimony should be treated as a starting point for clinical care and scientific inquiry. Restoring trust requires institutions to listen without prejudice, investigate uncertainty openly, report adverse events effectively, and ensure that no patient reporting vaccine-related injury is left without care, recognition, or hope.

Authors

Institutions

Publication Details

Journal
Journal of Independent Medicine
Published
2026-11-18
DOI
https://doi.org/10.71189/jim/2026/v02n06a09
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Vaccine Injury: Recognition, Research and Re-establishing Trust

Elizabeth A Mumper, Suzanne K. Gazda, Lawrence B. Palevsky
2 links
Journal of Independent Medicine
Pharmacovigilance and Adverse Drug Reactions
article

Vaccine Injury: Recognition, Research and Re-establishing Trust

Elizabeth A Mumper, Suzanne K. Gazda, Lawrence B. Palevsky
article en

Abstract

Background : Patients who report serious health changes following vaccination frequently face barriers to recognition, coordinated evaluation, and treatment. The October 5, 2026, Health and Human Services (HHS) Vaccine Injury Roundtable at the National Institutes of Health (NIH) brought patient, family, physician, and federal leadership perspectives into direct dialogue and highlighted an urgent need for compassionate care and rigorous inquiry. Clinical Perspectives : Three physicians described distinct but overlapping concerns. A pediatrician with extensive experience caring for children with autism and complex chronic illness called for research into biologic susceptibility, post-vaccination regression, and treatment strategies for affected children. A second pediatrician raised questions about chronic inflammation, neurodevelopmental conditions, vaccine components, and the need for research into individual vulnerability and long-term outcomes. A neurologist described complex, multi-system presentations among patients with suspected post-acute coronavirus disease 2019 (COVID-19) vaccination syndrome, including neurologic, autonomic, cognitive, cardiopulmonary, and immune-related symptoms. Call to Action : The authors commend HHS and NIH for establishing a clinic to study patients reporting vaccine-related injuries. However, the national need is for urgent clinical care and educating clinicians on how to deliver it. Priority actions include prospective longitudinal studies; standardized clinical phenotyping; transparent case definitions; improved adverse-event surveillance; research into genetic, metabolic, mitochondrial, immunologic, and inflammatory susceptibility factors; and a national network of multidisciplinary referral and treatment centers. Conclusions : Patient testimony should be treated as a starting point for clinical care and scientific inquiry. Restoring trust requires institutions to listen without prejudice, investigate uncertainty openly, report adverse events effectively, and ensure that no patient reporting vaccine-related injury is left without care, recognition, or hope.

Journal of Independent MedicineVol. 2(6)
Independent Medical Alliance (US)
Good health and well-being
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon